Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,644 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital Of Nanchang University Nanchang, Jiangxi, China
  • Shengjing Hospital of China Medical Shengyang, Liaoning, China
  • Blood Disease Hospital , Chinese Academy of Medical Science Tianjing, China
View Trial Details
Active, Not Recruiting

A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma

NCT03952078

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03934567

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 26 locations
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients

NCT04024696

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • Tianjin Medical University General Hospital Tianjin, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, China
View Trial Details
Active, Not Recruiting

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03600441

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Advocate Medical Group - Park Ridge, Luther Lane - Oncology Park Ridge, Illinois, United States
  • Norton Cancer Institute - St. Matthews Campus Louisville, Kentucky, United States
  • Clinical Research Alliance Inc Lake Success, New York, United States
  • Manhattan Hematology Oncology Center New York, United States
View all 15 locations
View Trial Details

Related conditions